Results 181 to 190 of about 7,123 (225)

Rituximab‐responsive CIDP

European Journal of Neurology, 2004
Chemotherapy has been used for treating chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with incosistent results. Chemotheraphy has been used for treating with inconsistent results. Rituximab is a chimeric monoclonal antibody directed against the CD20 antigen, used to treat B‐cell lymphoma and reported to be effective in some ...
BRIANI, CHIARA, ZARA G, ZAMBELLO R, TRENTIN, LIVIO, RANA M, ZAJA F.   +5 more
openaire   +3 more sources

Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP

Journal of Neurology, 2016
To investigate the use of nerve ultrasound (NUS) along with the European Federation of Neurological Societies (EFNS) guidelines and clinical scores in untreated, recently diagnosed chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) vs. long-lasting treated CIDP.
Alexander Grimm, Maria Rasenack, Bernhard F Décard   +2 more
exaly   +4 more sources

To CIDP or Not to CIDP

2018
POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes) is a rare paraneoplastic syndrome. It is generally associated with an underlying plasma cell neoplasm, most commonly osteosclerotic myeloma. The most common paraprotein identified is either IgG or IgA lambda.
Aaron E. Miller, Tracy M. DeAngelis, Michelle Fabian, Ilana Katz Sand   +3 more
openaire   +1 more source

CIDP: mimics and chameleons

Practical Neurology, 2014
The diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is usually straightforward, but atypical presentations can represent a significant diagnostic challenge. This review highlights the clinical and electrophysiological ‘red flags’ that should make one consider an alternative diagnosis.
A, Neligan, M M, Reilly, M P, Lunn
openaire   +2 more sources

CIDP PRESENTING AS MYELORADICULOPATHY

INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, 2021
Chronic inammatory demyelinating polyradiculoneuropathy (CIDP) is a relapsing or chronic progressive disorder which is one of the causes of hypertrophic neuropathy. Enlarged nerve roots were identied in few patients. We now report a case of CIDP with highly thickened or enlarged nerve roots severe enough to cause cord compression and myelopathy. A 38
Sundarachary. N.V, Mythri. A.
openaire   +1 more source

Diagnosis of CIDP

Neurology, 2002
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease that targets the myelin sheaths of peripheral nerves. In clinical practice the diagnosis is often difficult to make because of the clinical heterogeneity of the disease, its multifocality and predilection for proximal nerve segments, and the limitations of our ...
openaire   +2 more sources

MR neurography for the evaluation of CIDP

Muscle & Nerve, 2016
ABSTRACT Introduction : To visualize peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy (CIDP), we used MR imaging. We also quantified the volumes of the brachial and lumbar plexus and their nerve roots.
Tomomasa, Ishikawa, Kunihiko, Asakura, Yasuaki, Mizutani, Akihiro, Ueda, Ken-Ichiro, Murate, Chika, Hikichi, Sayuri, Shima, Madoka, Kizawa, Masako, Komori, Kazuhiro, Murayama, Hiroshi, Toyama, Shinji, Ito, Tatsuro, Mutoh   +12 more
openaire   +2 more sources

The pathogenesis of CIDP

Neurology, 2003
Current knowledge about the pathogenic mechanisms involved in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) supports an autoimmune etiology. Some of the cell and humorally mediated immune responses that contribute to the development of CIDP resemble those implicated in multiple sclerosis (MS).
Klaus V, Toyka, Ralf, Gold
openaire   +2 more sources

Current treatments for CIDP

Neurology, 2003
This article reviews the efficacy and tolerability of currently available therapies, including intravenous immunoglobulin (IVIg), corticosteroids, and plasma exchange (PE), for treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Data show that current therapies are effective in approximately two-thirds of patients.
openaire   +2 more sources

Electrophysiologic correlations with clinical outcomes in CIDP

Muscle & Nerve, 2010
AbstractData are lacking on correlations between changes in nerve conduction (NC) studies and treatment response in chronic inflammatory demyelinating polyneuropathy (CIDP). This report examined data from a randomized, double‐blind trial of immune globulin intravenous, 10% caprylate/chromatography purified (IGIV‐C [Gamunex]; n = 59) versus placebo (n =
Bril, V, Banach, M, Dalakas, Mc, Deng, C, Donofrio, P, Hanna, K, Hartung, Hp, Hughes, Ra, Katzberg, H, Latov, N, Merkies, Is, Van Doorn, Pa, Ice, Sg, Adamova, B, Apostolski, S, Barroso, F, Basta, I, Bednarik, J, Benedetti, L, Buchman, A, Caress, J, Chapman, J, Chapman, K, Cho, S, Comi, G, Del Carro, U, Drory, V, Dubrovsky, A, Ehler, E, Fazio, R, Fulgenzi, E, Gibson, G, Gonzalez Cornejo, S, GRANDIS, MARINA, Kostera Pruszczyk, A, Kwiecinski, H, Marchesoni, C, Meluzinova, E, Munch, C, Nations, S, Nogue'S, M, Oh, S, Pardal, A, Patwa, H, Pavlovic, S, Pikova Libertinova, J, Pizzorno, M, Reisin, R, Rivero, A, Romero Vargas, S, Ruiz Sandoval, J, Selmaj, K, Szczudlik, A, Thomas, Fp, Trivedi, J, Tsao, B, Villa, A, Vohanka, S, Wolfe, G.   +58 more
openaire   +4 more sources